TNFRSF10A and cancer: The TRAIL selectively promotes apoptosis by interacting with death receptors TRAIL-R1 (or DR4) and TRAIL-R2 (or DR5), which are excessively expressed in different types of cancer cells.24 In addition, low or no expression of decoy receptors should be observed on the targeted cell.